NCT00138931 Genetics of Cardiovascular and Neuromuscular Disease
| NCT ID | NCT00138931 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Chicago |
| Condition | Cardiomyopathy |
| Study Type | OBSERVATIONAL |
| Enrollment | 2,000 participants |
| Start Date | 1996-09 |
| Primary Completion | 2030-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 2,000 participants in total. It began in 1996-09 with a primary completion date of 2030-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
We are studying the genetics of human cardiovascular and neuromuscular disease. There are many different genetic regions that have been associated with the development of cardiomyopathy. An equal number of genetic regions have been associated with muscular dystrophy and there is overlap because some of the identical genes, when mutated, produce both cardiomyopathy and muscular dystrophy. We are working to identify genes and gene mutations associated with cardiomyopathy, arrhythmias and muscular dystrophy. We propose to screen these samples for mutations in genes known to be involved in these disorders.
Eligibility Criteria
Inclusion Criteria: * Patients of all ages will be considered for the study. In particular, families with more than one affected relative will be sought. Exclusion Criteria: * Subjects without a suspected inherited cardiovascular or neuromuscular disorder will be excluded from this study.
Contact & Investigator
Elizabeth McNally, MD PhD
PRINCIPAL INVESTIGATOR
University of Chicago
Frequently Asked Questions
Who can join the NCT00138931 clinical trial?
This trial is open to participants of all sexes, studying Cardiomyopathy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT00138931 currently recruiting?
Yes, NCT00138931 is actively recruiting participants. Contact the research team at Ldellefa@medicine.bsd.uchicago.edu for enrollment information.
Where is the NCT00138931 trial being conducted?
This trial is being conducted at Chicago, United States.
Who is sponsoring the NCT00138931 clinical trial?
NCT00138931 is sponsored by University of Chicago. The principal investigator is Elizabeth McNally, MD PhD at University of Chicago. The trial plans to enroll 2,000 participants.